16-56497063-G-C

Variant summary

Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_031885.5(BBS2):​c.1814C>G​(p.Ser605*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000031 in 1,612,570 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000021 ( 0 hom. )

Consequence

BBS2
NM_031885.5 stop_gained

Scores

5
1
1

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:5

Conservation

PhyloP100: 7.92

Publications

2 publications found
Variant links:
Genes affected
BBS2 (HGNC:967): (Bardet-Biedl syndrome 2) This gene is a member of the Bardet-Biedl syndrome (BBS) gene family. Bardet-Biedl syndrome is an autosomal recessive disorder characterized by severe pigmentary retinopathy, obesity, polydactyly, renal malformation and cognitive disability. The proteins encoded by BBS gene family members are structurally diverse and the similar phenotypes exhibited by mutations in BBS gene family members is likely due to their shared roles in cilia formation and function. Many BBS proteins localize to the basal bodies, ciliary axonemes, and pericentriolar regions of cells. BBS proteins may also be involved in intracellular trafficking via microtubule-related transport. The protein encoded by this gene forms a multiprotein BBSome complex with seven other BBS proteins.[provided by RefSeq, Oct 2014]
BBS2 Gene-Disease associations (from GenCC):
  • Bardet-Biedl syndrome 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Myriad Women’s Health
  • ciliopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • retinitis pigmentosa 74
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Bardet-Biedl syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 18 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 16-56497063-G-C is Pathogenic according to our data. Variant chr16-56497063-G-C is described in CliVar as Pathogenic. Clinvar id is 553335.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56497063-G-C is described in CliVar as Pathogenic. Clinvar id is 553335.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56497063-G-C is described in CliVar as Pathogenic. Clinvar id is 553335.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56497063-G-C is described in CliVar as Pathogenic. Clinvar id is 553335.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56497063-G-C is described in CliVar as Pathogenic. Clinvar id is 553335.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56497063-G-C is described in CliVar as Pathogenic. Clinvar id is 553335.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56497063-G-C is described in CliVar as Pathogenic. Clinvar id is 553335.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56497063-G-C is described in CliVar as Pathogenic. Clinvar id is 553335.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56497063-G-C is described in CliVar as Pathogenic. Clinvar id is 553335.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56497063-G-C is described in CliVar as Pathogenic. Clinvar id is 553335.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56497063-G-C is described in CliVar as Pathogenic. Clinvar id is 553335.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56497063-G-C is described in CliVar as Pathogenic. Clinvar id is 553335.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56497063-G-C is described in CliVar as Pathogenic. Clinvar id is 553335.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56497063-G-C is described in CliVar as Pathogenic. Clinvar id is 553335.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56497063-G-C is described in CliVar as Pathogenic. Clinvar id is 553335.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56497063-G-C is described in CliVar as Pathogenic. Clinvar id is 553335.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56497063-G-C is described in CliVar as Pathogenic. Clinvar id is 553335.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56497063-G-C is described in CliVar as Pathogenic. Clinvar id is 553335.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56497063-G-C is described in CliVar as Pathogenic. Clinvar id is 553335.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56497063-G-C is described in CliVar as Pathogenic. Clinvar id is 553335.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56497063-G-C is described in CliVar as Pathogenic. Clinvar id is 553335.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56497063-G-C is described in CliVar as Pathogenic. Clinvar id is 553335.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56497063-G-C is described in CliVar as Pathogenic. Clinvar id is 553335.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BBS2NM_031885.5 linkc.1814C>G p.Ser605* stop_gained Exon 15 of 17 ENST00000245157.11 NP_114091.4 Q9BXC9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BBS2ENST00000245157.11 linkc.1814C>G p.Ser605* stop_gained Exon 15 of 17 1 NM_031885.5 ENSP00000245157.5 Q9BXC9
ENSG00000288725ENST00000684388.1 linkn.734C>G non_coding_transcript_exon_variant Exon 6 of 14 ENSP00000507647.1 A0A804HJU2

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152204
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00000795
AC:
2
AN:
251422
AF XY:
0.0000147
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000205
AC:
3
AN:
1460248
Hom.:
0
Cov.:
30
AF XY:
0.00000275
AC XY:
2
AN XY:
726550
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33446
American (AMR)
AF:
0.00
AC:
0
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26120
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39688
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86236
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53418
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1110530
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60322
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.408
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152322
Hom.:
0
Cov.:
32
AF XY:
0.0000134
AC XY:
1
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.0000240
AC:
1
AN:
41580
American (AMR)
AF:
0.00
AC:
0
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68034
Other (OTH)
AF:
0.00
AC:
0
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000151

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Bardet-Biedl syndrome 2 Pathogenic:3
-
Department of Pediatrics, National Cheng-Kung University Hospital
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Aug 15, 2017
Counsyl
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -

May 13, 2023
Baylor Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Bardet-Biedl syndrome Pathogenic:1
Aug 11, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 553335). This premature translational stop signal has been observed in individual(s) with BBS2-related conditions (PMID: 25999675, 27659767). This variant is present in population databases (rs201063733, gnomAD 0.003%). This sequence change creates a premature translational stop signal (p.Ser605*) in the BBS2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BBS2 are known to be pathogenic (PMID: 11285252, 20177705, 24608809, 26518167). -

Bardet-Biedl syndrome 2;C4225281:Retinitis pigmentosa 74 Pathogenic:1
Dec 15, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.56
D
BayesDel_noAF
Pathogenic
0.66
CADD
Pathogenic
40
DANN
Uncertain
0.99
Eigen
Pathogenic
1.1
Eigen_PC
Pathogenic
0.96
FATHMM_MKL
Pathogenic
1.0
D
PhyloP100
7.9
Vest4
0.82, 0.83
GERP RS
5.1
Mutation Taster
=8/192
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.10
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201063733; hg19: chr16-56530975; API